Compass Therapeutics, Inc.

New Filing

CIK: 0001738021·Other·DELAWARE·Filed: Jul 1, 2020

Total Offering

$195,276,780

Amount Sold

$195,276,780

Investors

114

First Sale

Jun 17, 2020

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2018
Non-Accredited Investors: No

Related Persons

Name	Role
Julie Sunderland	Related Person
Carl L. Gordon	Related Person
THOMAS J SCHUETZ	Related Person
Philip Ferneau	Related Person
Stephen P. Squinto	Related Person
VERED BISKER-LEIB	Related Person

Company

Compass Therapeutics, Inc.

245 FIRST STREET, 3RD FLOOR

CAMBRIDGE, MA, 02142

617-500-8099

SEC Filing

0001802806-20-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.